acm-header
Sign In

Communications of the ACM

Careers


Featured Job
bg-corner

There Is a Blind Spot in AI Research
From ACM Opinion

There Is a Blind Spot in AI Research

This week, the White House published its report on the future of artificial intelligence (AI)—a product of four workshops held between May and July 2016 in Seattle...

Why Big Pharma Wants to Collect 2 Million Genomes
From ACM Opinion

Why Big Pharma Wants to Collect 2 Million Genomes

Five months after announcing its intentions to gather genome sequences from 2 million people, pharmaceutical giant AstraZeneca has selected geneticist David Goldstein...

Titanic Clash Over Crispr Patents Turns Ugly
From ACM Careers

Titanic Clash Over Crispr Patents Turns Ugly

Geneticist George Church has pioneered methods for sequencing and altering genomes.

Europe Proposes Copyright Reform to Help Scientists Mine Research Papers
From ACM Careers

Europe Proposes Copyright Reform to Help Scientists Mine Research Papers

The European Commission has announced long-awaited plans to make it easier for researchers to harvest facts and data from research papers—by freeing the computer...

Why Scientists Must Share Their Research Code
From ACM Opinion

Why Scientists Must Share Their Research Code

Many scientists worry over the reproducibility of wet-lab experiments, but data scientist Victoria Stodden's focus is on how to validate computational research:...

Obama's Science Legacy: Betting Big on Biomedical Science
From ACM Opinion

Obama's Science Legacy: Betting Big on Biomedical Science

When president-elect Barack Obama chose physicist John Holdren as his top science adviser in December 2008, some biomedical researchers worried that the pick signalled...

Replications, Ridicule and a Recluse: The Controversy Over Ngago Gene-Editing Intensifies
From ACM Careers

Replications, Ridicule and a Recluse: The Controversy Over Ngago Gene-Editing Intensifies

A controversy is escalating over whether a gene-editing technique proposed as an alternative to the popular CRISPR–Cas9 system actually works.

The ­nsung Heroes of Crispr
From ACM Careers

The ­nsung Heroes of Crispr

When Blake Wiedenheft started studying microbes, his work was both remote and obscure.

Plan to Synthesize Human Genome Elicits Mixed Response
From ACM News

Plan to Synthesize Human Genome Elicits Mixed Response

Proposals for a large public-private initiative to synthesize an entire human genome from scratch—an effort that could take a decade and require billions of dollars...

Digital Forensics: From the Crime Lab to the Library
From ACM News

Digital Forensics: From the Crime Lab to the Library

When archivists at California's Stanford University received the collected papers of the late palaeontologist Stephen Jay Gould in 2004, they knew right away they...

1,500 Scientists Lift the Lid on Reproducibility
From ACM News

1,500 Scientists Lift the Lid on Reproducibility

More than 70% of researchers have tried and failed to reproduce another scientist's experiments, and more than half have failed to reproduce their own experiments...

Uk Graphene Inquiry Reveals Commercial Struggles
From ACM Careers

Uk Graphene Inquiry Reveals Commercial Struggles

The £61-million (US$89-million) National Graphene Institute (NGI) at the University of Manchester, UK, has been open for little more than a year. But a parliamentary...

The Quiet Revolutionary: How the Co-Discovery of CRISPR Explosively Changed Emmanuelle Charpentier’s Life
From ACM Careers

The Quiet Revolutionary: How the Co-Discovery of CRISPR Explosively Changed Emmanuelle Charpentier’s Life

Emmanuelle Charpentier's office is bare, save for her computer.

'minimal' Cell Raises Stakes in Race to Harness Synthetic Life
From ACM News

'minimal' Cell Raises Stakes in Race to Harness Synthetic Life

Genomics entrepreneur Craig Venter has created a synthetic cell that contains the smallest genome of any known, independent organism.

Legal Tussle Delays Launch of Huge Toxicity Database
From ACM Careers

Legal Tussle Delays Launch of Huge Toxicity Database

A giant database on the health risks of nearly 10,000 chemicals will make it easier to predict the toxicity of tens of thousands of consumer products for which...

Bitter Fight Over Crispr Patent Heats Up
From ACM News

Bitter Fight Over Crispr Patent Heats Up

A versatile technique for editing genomes has been called the biggest biotechnology advancesince the polymerase chain reaction (PCR), and the US Patent and Trademark...

How to Judge Scientists' Strengths
From ACM Careers

How to Judge Scientists' Strengths

When the director of a research institute asked his Twitter followers for a practical way to dig out promising candidates from the hundreds of applications sitting...

Synthetic Biology Lures Silicon Valley Investors
From ACM Careers

Synthetic Biology Lures Silicon Valley Investors

In 2012, Emily Leproust was trying to raise money to start Twist Bioscience, a company that aimed to synthesize DNA more quickly and more cheaply than existing...

­se of Personalized Cancer Drugs Runs Ahead of the Science
From ACM News

­se of Personalized Cancer Drugs Runs Ahead of the Science

As the costs of genetic sequencing fall, oncologists are starting to prescribe expensive new drugs that target the genetic profiles of their patients' tumours,...

Private Firms Spy a Market in Spotting Space Junk
From ACM Careers

Private Firms Spy a Market in Spotting Space Junk

The US military has long taken the role of traffic cop in space: monitoring satellites, tracking debris and, in recent years, warning satellite operators and foreign...
Sign In for Full Access
» Forgot Password? » Create an ACM Web Account